Skip to main content
Year archive

Lee's Pharmaceutical Holdings Limited — 2021 filings

All 79 regulatory filings released by Lee's Pharmaceutical Holdings Limited (950) in 2021, sourced directly from the official regulator.

79 Filings
2021 Period
2021 filings (79)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings
2021-12-01 English
Third Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-30 English
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2021
Interim / Quarterly Report 9M 2021
2021-11-25 English
Voluntary Announcement - Update on an Investigational Oncology Drug Product
Regulatory Filings
2021-11-16 English
Notice of Board Meeting
Regulatory Filings
2021-11-15 English
Supplemental Announcement Regarding Annual Report for the Year Ended 31 December 2020
Regulatory Filings
2021-11-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Share Issue/Capital Change
2021-11-02 English
Voluntary Announcement - Business Update on the In-Licensing and Research and Development of Tafoxiparin of the Group
Regulatory Filings
2021-10-27 English
Voluntary Announcement - New Drug Application of Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer Submitted and Accepted by NMPA
Regulatory Filings
2021-10-27 English
Voluntary Announcement - Update on the Commercialisation and Research and Development of Cetraxal Plus of the Group
Regulatory Filings
2021-10-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings
2021-10-04 English
Voluntary Announcement - Update on the Research and Development of an Investigational Oncology Product
Regulatory Filings
2021-09-27 English
Interim Report 2021
Interim / Quarterly Report H1 2021
2021-09-13 English
Voluntary Announcement - Update on an Investigational Gynecology Drug Product
Regulatory Filings
2021-09-13 English
Voluntary Announcement - Appointment of Chief Medical Officer
Board/Management Information
2021-09-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Share Issue/Capital Change
2021-09-01 English
Interim Dividend for the Six Months Ended 30 June 2021
Notice of Dividend Amount
2021-08-26 English
Interim Results for the Six Months Ended 30 June 2021
Interim / Quarterly Report H1 2021
2021-08-26 English
Notice of Board Meeting
Regulatory Filings
2021-08-16 English
Positive Profit Alert
Earnings Release H1 2021
2021-08-13 English
Voluntary Announcement - Business Update on an Investigational Continuous Glucose Monitoring System of an Associated Company of the Group
Regulatory Filings
2021-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Share Issue/Capital Change
2021-08-02 English
Voluntary Announcement - Update on an Investigational Oncology Drug Product
Regulatory Filings
2021-07-22 English
Environmental, Social and Governance Report 2020
Environmental & Social Information
2021-07-16 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2021-07-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
Share Issue/Capital Change
2021-07-02 English
List of Directors and their Roles and Functions
Board/Management Information
2021-06-30 English
Resignation of Non-Executive Director
Board/Management Information
2021-06-30 English
Voluntary Announcement - Business Update on the Licensed-in of Bredinin from Asahi Kasei Pharma Corporation
Capital/Financing Update
2021-06-21 English
Voluntary Announcement - Official Release of the Result of Phase I Clinical Trial on the Safety and Antithrombotic Efficacy of Anfibatide
Regulatory Filings
2021-06-07 English
Voluntary Announcement - Business Update on the In-licensing and Research and Development of Tafoxiparin of the Group
Capital/Financing Update
2021-06-02 English
First Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
Capital/Financing Update
2021-06-01 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2021-05-28 English
First Quarterly Results Announcement for the Three Months Ended 31 March 2021
Interim / Quarterly Report Q1 2021
2021-05-27 English
Annual General Meeting Held on 24 May 2021 - Poll Results
Declaration of Voting Results & Voting Rights Announcements
2021-05-24 English
Voluntary Announcement - Sodium Phenylbutyrate Granules Obtained Approval for Drug Registration
Regulatory Filings
2021-05-21 English
Notice of Board Meeting
Regulatory Filings
2021-05-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Share Issue/Capital Change
2021-05-03 English
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Listing of Zhaoke Ophthalmology and Commencement of Dealings
Capital/Financing Update
2021-04-29 English
List of Directors and their Role and Function
Board/Management Information
2021-04-29 English
Terms of Reference of the Management Committee
Governance Information
2021-04-29 English
(1) Establishment of Management Committee&#x3b; (2) Resignation of Chief Executive Officer and Re-designation of Director&#x3b; and (3) Change of Authorised Representative
Board/Management Information
2021-04-29 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2021-04-28 English
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Final Offer Price
Capital/Financing Update
2021-04-28 English
Grant of Share Options
Director's Dealing
2021-04-21 English
Proxy Form
AGM Information
2021-04-21 English
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, and Notice of Annual General Meeting
AGM Information
2021-04-21 English
Notice of Annual General Meeting
AGM Information
2021-04-21 English
Annual Report 2020
Annual Report FY 2020
2021-04-21 English
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Publication of The Prospectus and Expected Size of The Global Offering an
Capital/Financing Update
2021-04-16 English
Voluntary Announcement - Update on Research and Development of an Investigational Ophthalmology Product of an Associated Company of the Group
Regulatory Filings
2021-04-12 English
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Post Hearing Information Pack
Report Publication Announcement
2021-04-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Share Issue/Capital Change
2021-04-01 English
Announcement of Annual Results for the year ended 31 December 2020
Annual Report FY 2020
2021-03-30 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2021-03-26 English
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange - Record Date, Closure of Register of Members and Basis of The Assured Enti
Capital/Financing Update
2021-03-23 English
Notice of Board Meeting
Regulatory Filings
2021-03-18 English
Extraordinary General Meeting Held on 15 March 2021 - Poll Results
Declaration of Voting Results & Voting Rights Announcements
2021-03-15 English
Voluntary Announcement - Update on an Investigational Direct Oral Anticoagulant
Regulatory Filings
2021-03-11 English
Voluntary Announcement - Update on an Investigational Ophthalmology Product of an Associated Company of the Group
Regulatory Filings
2021-03-11 English
Voluntary Announcement - Socazolimab Obtained Approval for a Phase III Clinical Trial from NMPA
Regulatory Filings
2021-03-05 English
Voluntary Announcement - Update of Business Development with KPC Pharmaceuticals, Inc.
Regulatory Filings
2021-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Share Issue/Capital Change
2021-03-01 English
Proxy Form for use by Shareholders at the Extraordinary General Meeting
Proxy Solicitation & Information Statement
2021-02-24 English
Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange and Notice of Extraordinary General Meeting
Proxy Solicitation & Information Statement
2021-02-24 English
Notice of Extraordinary General Meeting
AGM Information
2021-02-24 English
Further Delay in Despatch of Circular - Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange
Report Publication Announcement
2021-02-11 English
Voluntary Announcement - Update on the Research and Development of an Investigational Oncology Product
Regulatory Filings
2021-02-09 English
Voluntary Announcement - Update on an Investigational Dermatology Product
Regulatory Filings
2021-02-09 English
Voluntary Announcement - Fondaparinux Sodium Injection Obtained Approval for Drug Registration
Regulatory Filings
2021-02-05 English
Voluntary Announcement - Update on an Investigational Oncology Product
Regulatory Filings
2021-02-05 English
Voluntary Announcement - Memorandum of Understanding of an Associated Company in relation to the Strategic Partnership with Singapore Eye Research Institute
Regulatory Filings
2021-02-02 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2021-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Capital/Financing Update
2021-02-01 English
Delay in Despatch of Circular - Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange
Regulatory Filings
2021-01-29 English
Voluntary Announcement - Update on an Investigational Gynecology Drug Product
Regulatory Filings
2021-01-15 English
Voluntary Announcement - Update on an Investigational Ear Drug Product
Regulatory Filings
2021-01-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Regulatory Filings
2021-01-04 English